Who owns Spero Therapeutics Inc?
- Ticker: SPRO
- CUSIP Number: 84833t103
Tip: Access positions for across all investors
Analyze quarterly positions in Spero Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Spero Therapeutics stock
Who bought or sold Spero Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| GSK | 9.2M | $20M | 100% | Jun 2026 |
|
| Pfizer | 2.4M | $5.3M | 0% | Jun 2026 |
|
| Vanguard Capital Management | 2.0M | $4.5M | 13% | Jun 2026 |
|
| Renaissance Technologies | 948k | $2.1M | -20% | Jun 2026 |
|
| Alphabet | 890k | $2.0M | 0% | Jun 2026 |
|
| Susquehanna International | 808k | $1.8M | 112% | Jun 2026 |
|
| BlackRock | 594k | $1.3M | 37% | Jun 2026 |
|
| Geode Capital Management | 566k | $1.3M | 9% | Jun 2026 |
|
| Raymond James Financial | 522k | $1.2M | 100% | Jun 2026 |
|
| Two Sigma Investments | 383k | $846k | -57% | Jun 2026 |
|
| Arrowstreet Capital, Limited Partnership | 333k | $736k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 288k | $636k | 9% | Jun 2026 |
|
| GSA Capital Partners | 286k | $632k | 3% | Jun 2026 |
|
| Dimensional Fund Advisors | 275k | $607k | 823% | Jun 2026 |
|
| Goldman Sachs Group | 257k | $568k | 100% | Jun 2026 |
|
| Jane Street | 232k | $513k | 27% | Jun 2026 |
|
| State Street Corporation | 215k | $503k | 2% | Mar 2026 |
|
| UBS Group | 140k | $309k | 4542% | Jun 2026 |
|
| Bridgeway Capital Management | 115k | $254k | 0% | Jun 2026 |
|
| Northern Trust | 108k | $239k | -11% | Jun 2026 |
|
| Point72 Asset Management | 104k | $231k | 75% | Jun 2026 |
|
| Ionic Capital Management | 103k | $227k | -48% | Jun 2026 |
|
| Federation des caisses Desjardins du Quebec | 92k | $202k | 100% | Jun 2026 |
|
| Shay Capital | 72k | $160k | 3% | Jun 2026 |
|
| Citadel Advisors | 66k | $145k | -85% | Jun 2026 |
|
| Invesco | 64k | $142k | 42% | Jun 2026 |
|
| Simplex Trading | 61k | $136k | 102% | Jun 2026 |
|
| Verdad Advisers | 51k | $114k | 53% | Jun 2026 |
|
| XTX Topco | 51k | $112k | 100% | Jun 2026 |
|
| American Century Companies | 37k | $81k | 100% | Jun 2026 |
|
| Axxcess Wealth Management | 33k | $72k | 100% | Jun 2026 |
|
| Capital Asset Advisory Services | 33k | $72k | 0% | Jun 2026 |
|
| DLK Investment Management | 31k | $41k | 100% | Jun 2026 |
|
| Three Seasons Wealth | 30k | $66k | 0% | Jun 2026 |
|
| Charles Schwab Investment Management | 29k | $63k | 0% | Jun 2026 |
|
| Sixth Street Partners Management Company | 29k | $63k | 100% | Jun 2026 |
|
| Vanguard Global Advisers | 25k | $56k | 0% | Jun 2026 |
|
| Global Retirement Partners | 25k | $55k | 100% | Jun 2026 |
|
| Oppenheimer & Co | 23k | $51k | 100% | Jun 2026 |
|
| Millennium Management | 19k | $43k | 100% | Jun 2026 |
|
| Citigroup | 19k | $45k | 100% | Mar 2026 |
|
| Assenagon Asset Management | 19k | $41k | 0% | Jun 2026 |
|
| Susquehanna Portfolio Strategies | 18k | $39k | 100% | Jun 2026 |
|
| Susquehanna Fundamental Investments | 16k | $36k | 100% | Jun 2026 |
|
| Qube Research & Technologies | 14k | $30k | 100% | Jun 2026 |
|
| SG Americas Securities | 11k | $25k | 100% | Jun 2026 |
|
| Group One Trading | 11k | $24k | 100% | Jun 2026 |
|
| Two Sigma Securities | 11k | $23k | 100% | Jun 2026 |
|
| Prudential Financial | 10k | $23k | 100% | Jun 2026 |
|
| FNY Investment Advisers | 8.3k | $18k | 57% | Jun 2026 |
|
| Jones Financial Companies, L.L | 7.7k | $17k | 0% | Jun 2026 |
|
| Morgan Stanley | 4.6k | $11k | 1354% | Mar 2026 |
|
| Royal Bank of Canada | 2.0k | $4.0k | 100% | Jun 2026 |
|
| FMR | 300.00 | $663.000000 | 100% | Jun 2026 |
|
| Advisor Group Holdings | 290.00 | $640.001000 | 0% | Jun 2026 |
|
| Jpmorgan Chase & Co | 236.00 | $533.006000 | 100% | Jun 2026 |
|
| Wells Fargo & Company | 200.00 | $442.000000 | 0% | Jun 2026 |
|
| Rialto Wealth Management | 172.00 | $380.997200 | 100% | Jun 2026 |
|
| Us Bancorp | 151.00 | $333.996900 | 0% | Jun 2026 |
|
| SBI Securities | 13.00 | $29.000400 | 44% | Jun 2026 |
|
| Farther Finance Advisors | 10.00 | $22.000000 | 0% | Jun 2026 |
|
Who sold out of Spero Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Frigate Ventures | Mar 2026 | 422k | $987k |
| Squarepoint Ops | Mar 2026 | 194k | $455k |
| Marshall Wace | Mar 2026 | 157k | $368k |
| Quadrature Capital | Mar 2026 | 40k | $94k |
| OMERS Administration Corporation | Mar 2026 | 39k | $92k |
| Schonfeld Strategic Advisors | Mar 2026 | 20k | $48k |
| Torrey Growth & Income Advisors | Mar 2026 | 17k | $38k |
| Occudo Quantitative Strategies | Mar 2026 | 16k | $41k |
| Intrepid Family Office | Mar 2026 | 16k | $38k |
| Bnp Paribas Arbitrage, Snc | Mar 2026 | 40.00 | $94.000000 |
| SageView Advisory Group | Dec 2025 | 17.00 | $39.999300 |